Fall-related activity avoidance in relation to a history of falls or near falls, fear of falling and disease severity in people with Parkinson’s disease
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2377
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Fall-related activity avoidance in relation to a history of falls or near falls, fear of falling and disease severity in people with Parkinson’s disease ; volume:16 ; number:1 ; day:2 ; month:6 ; year:2016 ; pages:1-8 ; date:12.2016
BMC neurology ; 16, Heft 1 (2.6.2016), 1-8, 12.2016
- Urheber
-
Kader, Manzur
- Beteiligte Personen und Organisationen
- DOI
-
10.1186/s12883-016-0612-5
- URN
-
urn:nbn:de:1111-2016060325597
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:44 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Kader, Manzur
- Iwarsson, Susanne
- Odin, Per
- Nilsson, Maria H.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Development of a Parkinson’s disease specific falls questionnaire
Falls risk is predictive of dysphagia in Parkinson’s disease
Assessment of fall-related self-efficacy and activity avoidance in people with Parkinson's disease
Prognostic factors for falls in Parkinson’s disease: a systematic review
Longitudinal prediction of falls and near falls frequencies in Parkinson’s disease: a prospective cohort study
Development and Validation of a Fall Questionnaire for Patients with Parkinson’s Disease
Factors associated with fear of falling in people with Parkinson’s disease
Cholinesterase inhibitor to prevent falls in Parkinson’s disease (CHIEF-PD) trial: a phase 3 randomised, double-blind placebo-controlled trial of rivastigmine to prevent falls in Parkinson’s disease
Brain metabolic alterations herald falls in patients with Parkinson's disease
External validation of a 3-step falls prediction model in mild Parkinson’s disease
Axial impairment and falls in Parkinson’s disease: 15 years of subthalamic deep brain stimulation
Experiences of fear of falling in persons with Parkinson’s disease – a qualitative study
Development of a Parkinson’s disease specific falls questionnaire
Falls risk is predictive of dysphagia in Parkinson’s disease
Assessment of fall-related self-efficacy and activity avoidance in people with Parkinson's disease
Prognostic factors for falls in Parkinson’s disease: a systematic review
Longitudinal prediction of falls and near falls frequencies in Parkinson’s disease: a prospective cohort study
Development and Validation of a Fall Questionnaire for Patients with Parkinson’s Disease
Factors associated with fear of falling in people with Parkinson’s disease
Cholinesterase inhibitor to prevent falls in Parkinson’s disease (CHIEF-PD) trial: a phase 3 randomised, double-blind placebo-controlled trial of rivastigmine to prevent falls in Parkinson’s disease
Brain metabolic alterations herald falls in patients with Parkinson's disease
External validation of a 3-step falls prediction model in mild Parkinson’s disease
Axial impairment and falls in Parkinson’s disease: 15 years of subthalamic deep brain stimulation
Experiences of fear of falling in persons with Parkinson’s disease – a qualitative study
Development of a Parkinson’s disease specific falls questionnaire
Falls risk is predictive of dysphagia in Parkinson’s disease
Assessment of fall-related self-efficacy and activity avoidance in people with Parkinson's disease
Prognostic factors for falls in Parkinson’s disease: a systematic review
Longitudinal prediction of falls and near falls frequencies in Parkinson’s disease: a prospective cohort study
Development and Validation of a Fall Questionnaire for Patients with Parkinson’s Disease
Factors associated with fear of falling in people with Parkinson’s disease
Cholinesterase inhibitor to prevent falls in Parkinson’s disease (CHIEF-PD) trial: a phase 3 randomised, double-blind placebo-controlled trial of rivastigmine to prevent falls in Parkinson’s disease
Brain metabolic alterations herald falls in patients with Parkinson's disease
External validation of a 3-step falls prediction model in mild Parkinson’s disease
Axial impairment and falls in Parkinson’s disease: 15 years of subthalamic deep brain stimulation